Translating Germline Cancer Genomics into Precision Prevention of Cancer
It is well known that early detection and monitoring of cancer greatly improves patient prognosis. However, specific interventions are only
Tag : Precision Medicine
2 min read
Vanderbilt inks collaboration with precision neuroscience company Neumora to continue development of investigational treatment for neuropsychiatric disorders
Vanderbilt University has signed an exclusive, worldwide license and a research collaboration agreement with Neumora Therapeutics, Inc., a
3 min read
EVERSANA and Integra Connect Form Strategic Partnership
EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World
UNC-Chapel Hill leads two centers for $170 million NIH precision nutrition study
(CHAPEL HILL, N.C.) The University of North Carolina at Chapel Hill will play a large part in a new National Institutes of Health (NIH) precision
3 min read
From Precision Medicine to Precision Public Health: The Dialogue Continues
A recent Nature article discusses the concept of precision public health (PPH) and raises concerns that too much emphasis on data and technology is
2 min read
Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials
Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio
Sorting Cancers by Microenvironment Potentially Shifts the View on Immunotherapy
A study by researchers at the University of California, San Francisco (UCSF), demonstrates a new way of looking at cancer immunotherapy. The
6 min read
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A true testimony that we sit at the intersection of significant new opportunities The significant opportunities at the intersection of
6 min read
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A True Testimony that we Sit at The Intersection of Significant New Opportunities The significant opportunities at the intersection of
4 min read
Genomics and Precision Medicine 2021: Progress in Implementation, A Focus on Health Equity, and a New Public Health Initiative
In this post, we reflect on another eventful year in genomics and precision medicine and review the emerging opportunities for the field to make an
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patients MENLO
1 min read
Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars
One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with
Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease
The iHope Genetic Health program will expand access to whole-genome sequencing to low- and middle-income communities around the world, with more than
1 min read
Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment
Thomas Bock, M.D., Chief Executive Officer of Notable What You Should Know: – Coming out of stealth, Notable Labs, a pioneer and developer of
Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure
With an additional $100 million in funding, Color will use the infrastructure built during the pandemic to increase access to essential healthcare